Therefore, although IL-4 exhibits positive regulatory effects to boost insulin efficacy, the energy deposit-promoting activity of IL-4 may make the liver more susceptible to develop steatosis under insulin resistant and diabetic models. The gene discussed is IL4; the disease is steatosis.